Omaha Company drives vaccine development

Meridian Clinical Research is conducting the final phase of a COVID-19 vaccine study for Medicago, a Canada-based company developing a plant-based vaccine.

Some researchers believe the type of vaccine may cause fewer allergic reactions.

The medical director of “Meridian”, Dr. Brandon Essink, on 6 News, says, “When we have something that is really good we will just move on, but we just don’t know. And since this is all new to us, it is best to keep looking for something new search. ”

Essink adds: “In case something doesn’t work or this works better for the variants or if we have to work on it a little later.”

The company is looking for unvaccinated Nebraskans who have not been infected by Covid to participate in a study.

(Photo from 6 news)

Comments are closed.